摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

10-(12-bromododecyl)-10H-phenothiazine | 80548-36-3

中文名称
——
中文别名
——
英文名称
10-(12-bromododecyl)-10H-phenothiazine
英文别名
12-(10'-phenothiazinyl)dodecyl-1-bromide;10-(12-bromododecyl)phenothiazine
10-(12-bromododecyl)-10H-phenothiazine化学式
CAS
80548-36-3
化学式
C24H32BrNS
mdl
——
分子量
446.495
InChiKey
MZOPYJSKKJPOMK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.59
  • 重原子数:
    27.0
  • 可旋转键数:
    12.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    3.24
  • 氢给体数:
    0.0
  • 氢受体数:
    2.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    10-(12-bromododecyl)-10H-phenothiazineN-溴代丁二酰亚胺(NBS) 作用下, 以 二氯甲烷 为溶剂, 反应 10.0h, 以78.2%的产率得到
    参考文献:
    名称:
    一种具有(D-D-π-A)3结构的吩噻嗪染料及其 制备方法和应用
    摘要:
    本发明涉及一种具有(D‑D‑π‑A) 3 结构的吩噻嗪染料及其制备方法和应用,所述(D‑D‑π‑A) 3 结构的吩噻嗪染料具有式(VII)所示结构,其中R 1 、R 2 、R 3 、R 4 、P、D和L的定义见说明书。本发明还提供所述具有(D‑D‑π‑A) 3 结构的噻吩嗪染料的制备方法;本发明所述(D‑D‑π‑A) 3 结构的吩噻嗪染料能显著拓宽染料的光谱响应范围并增强染料的吸光强度。相比单D‑D‑π‑A结构的有机光敏染料,本发明提供的染料具有更大的摩尔吸光系数,将本发明所述的具有(D‑D‑π‑A) 3 结构的噻吩嗪染料用于制备染料敏化太阳能电池,可得到更大的短路电流密度(Jsc)。
    公开号:
    CN107698999B
  • 作为产物:
    描述:
    吩噻嗪1,12-二溴十二烷 在 sodium hydride 作用下, 以 四氢呋喃二甲基亚砜 为溶剂, 以50%的产率得到10-(12-bromododecyl)-10H-phenothiazine
    参考文献:
    名称:
    水溶液中吩噻嗪磺酸烷基酯胶束组装的研究
    摘要:
    已经对9-烷基吩噻嗪磺酸钠和ω-咔唑-9-烷基链烷磺酸钠(其中烷基= C 10 H 21和C 12 H 25)的胶束性质和光化学行为进行了研究,以用于胶束组件中光电离的基础研究。
    DOI:
    10.1039/f19868202615
点击查看最新优质反应信息

文献信息

  • Synthesis and Biochemical Characterization of New Phenothiazines and Related Drugs as MDR Reversal Agents
    作者:Matthias Schmidt、Marlen Teitge、Marianela E. Castillo、Tobias Brandt、Bodo Dobner、Andreas Langner
    DOI:10.1002/ardp.200800115
    日期:2008.10
    for pharmacophor structures is a promising strategy to increase the efficacy of those drugs still influencing multidrug resistance. In this study a range of phenothiazine derivatives was synthesizied with systematical variation of three molecule domains. The biochemical determination of multidrug resistance reversal activity was achieved with the crystalviolet assay on LLC‐PK1/MDR1 cells. The results
    化疗是治疗癌症最重要的方法之一。然而,化疗期间耐药性的发展是癌症患者治疗失败和生存率下降的主要原因。多药耐药 (MDR) 是 30 多年来广泛研究的耐药形式之一。ATP 结合盒蛋白家族的成员负责以 P-糖蛋白作为最具代表性的转运蛋白的多药耐药性。为了克服多药耐药性,外排泵抑制剂对转运蛋白的药理学调节似乎是首选,但临床前研究并未导致临床应用。因此,对药效基团结构进行系统研究是提高那些仍影响多药耐药性的药物疗效的有前途的策略。在这项研究中,一系列吩噻嗪生物合成了三个分子结构域的系统变异。多药耐药逆转活性的生化测定是通过对 LLC-PK1/MDR1 细胞的结晶紫测定实现的。将考虑文献中关于新的结构-活性关系以克服未来耐药性的假设来讨论结果。
  • Effect of Self-Assembly of Amphiphilic Redox-Chromophores on Photoionization Processes
    作者:Robin Humphry-Baker、André M. Braun、Michael Grätzel
    DOI:10.1002/hlca.19810640708
    日期:1981.11.4
    solution. Concomitantly with micellization, strong changes in the photochemical behaviour occur. In particular, monophotonic photoionization is only observed above the critical micelle concentration (CMC.). Cooperative effects associated with self-assembly of this amphiphilic redox chromophore leading to local electrostatic barriers are evoked to explain these effects.
    合成了吩噻嗪的表面活性剂衍生物,其能够在溶液中形成胶束。与胶束化同时,发生光化学行为的强烈变化。特别是,仅在临界胶束浓度(CMC。)以上才能观察到单光子光电离。引起与这种两亲性氧化还原生色团的自组装相关联的协同作用导致局部静电屏障,被认为是解释这些作用的原因。
  • Nakagaki, Ryoichi; Mutai, Kiyoshi; Hiramatsu, Mitsuo, Canadian Journal of Chemistry, 1988, vol. 66, p. 1989 - 1996
    作者:Nakagaki, Ryoichi、Mutai, Kiyoshi、Hiramatsu, Mitsuo、Tukada, Hideyuki、Nakakura, Saburo
    DOI:——
    日期:——
  • Comparative electron spin resonance and electron spin echo modulation studies of the photoionization of positively and negatively charged and neutral alkylphenothiazines in cationic dioctadecyldimethylammonium chloride, neutral dipalmitoylphosphatidylcholine, and anionic dihexadecyl phosphate vesicles at 77 K
    作者:Young Soo Kang、Hugh J. D. McManus、Larry Kevan
    DOI:10.1021/j100111a049
    日期:1993.3
    Positively charged phenothiazine N-alkyltrimethylammonium bromides (PC(n)TAB) and negatively charged sodium phenothiazine-N-alkanesulfonates (PC(n)S) were synthesized and photoionized in cationic dioctadecyldimethylammonium chloride (DODAC), neutral dipalmitoylphosphatidylcholine (DPPC), and anionic dihexadecyl phosphate (DHP) vesicles. The photoproduced radicals were identified and quantitated with electron spin resonance. The microenvironments of the various photoproduced PC(n)S and PC(n)TAB cation radicals in frozen D2O solutions were investigated with electron spin echo modulation (ESEM). These results are compared with those of neutral N-alkylphenothiazines (PC(n)) in the same vesicles. The effects of the pendent alkyl chain length on the photoyields of PC(n)S and PC(n)TAB are similar. For short alkyl chains (n = 2 or 3), a large deuteron modulation depth is observed, which correlates with a high photoyield. The large deuteron modulation depth indicates a short interaction distance between the phenothiazine radical and water at the interface. As the alkyl chain length of the anionic and cationic types of phenothiazines increases, the photoyield decreases reaching a minimum near six carbons. The decreased deuteron modulation depth indicates that the increased hydrophobic interaction of the phenothiazine alkyl chain with the vesicle surfactant alkyl chains pulls the phenothiazine group toward the interior of the vesicles, which results in a decrease of the photoyield. At still longer alkyl chain lengths (n = 12), the photoyield increases. This is explained by alkyl chain bending so that the phenothiazine moiety moves toward the vesicle interface region, which results in an increased photoyield. The effects of the pendent alkyl chain length of PC(n)TAB and PC(n)S contrast with those of PC(n) in the same vesicles. As the alkyl chain length of PC(n) increases, the photoyield decreases monotonically in DHP and DPPC vesicles with no evidence of alkyl chain bending. These photoyields are well supported by the ESEM results. In DODAC vesicles the photoyields and deuteron modulation depths decrease up to twelve carbons and then increase which is consistent with some alkyl chain bending. Overall, the photoionization yields and deuteron modulation depths show good self-consistency for all systems studied. For the same vesicle system the photoyields decrease in the order PC(n)S > PC(n)TAB > PC(n). This is explained by the greater hydrophilicity of the sulfonate group of PC(n)S relative to the trimethylammonium group in PC(n)TAB relative to the methyl group of PC(n). This difference locates the phenothiazine moiety closer to the interface region of the vesicles for greater hydrophilicity. These distance differences are verified by the ESE deuteron modulation depths. The photoyields for a given alkylphenothiazine series in the three different vesicles decrease as DODAC > DPPC > DHP. This constrasts with ESE deuteron modulation depths which decrease as DHP > DPPC > DODAC. This indicates that the photoyield for the same alkylphenothiazines in different vesicles is determined primarily by the energy barrier of the vesicle interface charge.
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)